Article
A bireporter recombinant SARS-CoV-2 Omicron BA.5 for <i>in vitro</i> and <i>in vivo</i> studies
2026-01-26
Abstract excerpt
<h4>ABSTRACT</h4> The continuous emergence of variants of concern (VoC) represent a significant challenge to effectively control SARS-CoV-2. Although FDA-approved vaccines and antivirals have been successfully developed and implemented for the prophylactic and therapeutic intervention of SARS-CoV-2 infection, recent VoC could escape protection garnered by previous vaccine and antiviral approaches. Determining the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 66a1d29c-2d29-5511-9e91-9b36f41f1910
- DOI
- 10.64898/2026.01.24.700018
